Latest news
Laura Alder: Tarlatamab Demonstrates Strong Responses in DLL3-High Pulmonary Carcinoid - OncodailyOncodaily · Sat, 08 Aug 2026 20:26:06 GMTLaura Alder: Registration Opens for "Bispecifics, ADCs and Beyond" - OncodailyOncodaily · Wed, 05 Aug 2026 19:08:35 GMTCommunity Access, Future Directions, and Key Takeaways for CNS Disease in EGFR-Mutated NSCLC - OncLiveOncLive · Tue, 04 Aug 2026 17:35:31 GMTLeptomeningeal Disease Management in EGFR-Mutated NSCLC: Systemic Therapy, Radiation, and Intrathecal Options - OncLiveOncLive · Tue, 28 Jul 2026 13:32:05 GMT